KARUNA THERAPEUTICS INC COM
(NASDAQ:KRTX)
$329.83
0[0.00%]
Last update: 7:21PM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$330.00
Lowest Price Target1
$174.00
Consensus Price Target1
$234.75

KARUNA THERAPEUTICS INC COM Stock (NASDAQ:KRTX), Analyst Ratings, Price Targets, Predictions

KARUNA THERAPEUTICS INC COM has a consensus price target of $234.75, established from looking at the 75 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on March 14, 2024, March 11, 2024, and February 20, 2024. With an average price target of $330 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 0.05% upside for KARUNA THERAPEUTICS INC COM from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
5
Dec 23
1
6
Jan
2
Feb
1
Mar
2
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Cantor Fitzgerald
Mizuho
JP Morgan
JMP Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for KARUNA THERAPEUTICS INC COM

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/14/2024KRTXBuy Now
Karuna Therapeutics
$329.830.05%HC Wainwright & Co.
Raghuram Selvaraju
$330 → $330MaintainsNeutralGet Alert
03/11/2024KRTXBuy Now
Karuna Therapeutics
$329.830.05%HC Wainwright & Co.
Raghuram Selvaraju
→ $330ReiteratesNeutral → NeutralGet Alert
02/20/2024KRTXBuy Now
Karuna Therapeutics
$329.830.05%Cantor Fitzgerald
Charles Duncan
→ $330ReiteratesNeutral → NeutralGet Alert
01/26/2024KRTXBuy Now
Karuna Therapeutics
$329.830.05%Mizuho
Vamil Divan
$245 → $330DowngradeBuy → NeutralGet Alert
01/17/2024KRTXBuy Now
Karuna Therapeutics
$329.830.05%Cantor Fitzgerald
Charles Duncan
→ $330ReiteratesNeutral → NeutralGet Alert
12/28/2023KRTXBuy Now
Karuna Therapeutics
$329.830.05%JP Morgan
Jessica Fye
$217 → $330DowngradeOverweight → NeutralGet Alert
12/26/2023KRTXBuy Now
Karuna Therapeutics
$329.830.05%HC Wainwright & Co.
Raghuram Selvaraju
$300 → $330DowngradeBuy → NeutralGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$329.83JMP Securities
Jason Butler
DowngradeMarket Outperform → Market PerformGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$329.830.05%Wedbush
Laura Chico
→ $330DowngradeOutperform → NeutralGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$329.83Guggenheim
Yatin Suneja
DowngradeBuy → NeutralGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$329.830.05%Morgan Stanley
Jeffrey Hung
$295 → $330DowngradeOverweight → Equal-WeightGet Alert
12/12/2023KRTXBuy Now
Karuna Therapeutics
$329.83-31.18%Deutsche Bank
Neena Bitritto-Garg
→ $227Initiates → BuyGet Alert
11/20/2023KRTXBuy Now
Karuna Therapeutics
$329.83-9.04%HC Wainwright & Co.
Raghuram Selvaraju
→ $300ReiteratesBuy → BuyGet Alert
11/17/2023KRTXBuy Now
Karuna Therapeutics
$329.83-3.59%JMP Securities
Jason Butler
→ $318ReiteratesMarket Outperform → Market OutperformGet Alert
11/17/2023KRTXBuy Now
Karuna Therapeutics
$329.83-23.29%Wedbush
Laura Chico
→ $253ReiteratesOutperform → OutperformGet Alert
11/03/2023KRTXBuy Now
Karuna Therapeutics
$329.83-31.78%RBC Capital
Brian Abrahams
$235 → $225MaintainsOutperformGet Alert
11/03/2023KRTXBuy Now
Karuna Therapeutics
$329.83-10.26%Goldman Sachs
Corinne Jenkins
$332 → $296MaintainsBuyGet Alert
11/03/2023KRTXBuy Now
Karuna Therapeutics
$329.83-23.29%Wedbush
Laura Chico
$250 → $253MaintainsOutperformGet Alert
09/28/2023KRTXBuy Now
Karuna Therapeutics
$329.83-9.04%HC Wainwright & Co.
Raghuram Selvaraju
→ $300ReiteratesBuy → BuyGet Alert

FAQ

Q

What is the target price for KARUNA THERAPEUTICS INC COM (KRTX)?

A

The latest price target for KARUNA THERAPEUTICS INC COM (NASDAQ: KRTX) was reported by HC Wainwright & Co. on March 14, 2024. The analyst firm set a price target for $330.00 expecting KRTX to rise to within 12 months (a possible 0.05% upside). 38 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for KARUNA THERAPEUTICS INC COM (KRTX)?

A

The latest analyst rating for KARUNA THERAPEUTICS INC COM (NASDAQ: KRTX) was provided by HC Wainwright & Co., and KARUNA THERAPEUTICS INC COM maintained their neutral rating.

Q

When was the last upgrade for KARUNA THERAPEUTICS INC COM (KRTX)?

A

There is no last upgrade for KARUNA THERAPEUTICS INC COM.

Q

When was the last downgrade for KARUNA THERAPEUTICS INC COM (KRTX)?

A

The last downgrade for KARUNA THERAPEUTICS INC COM happened on January 26, 2024 when Mizuho changed their price target from $245 to $330 for KARUNA THERAPEUTICS INC COM.

Q

When is the next analyst rating going to be posted or updated for KARUNA THERAPEUTICS INC COM (KRTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KARUNA THERAPEUTICS INC COM, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KARUNA THERAPEUTICS INC COM was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.

Q

Is the Analyst Rating KARUNA THERAPEUTICS INC COM (KRTX) correct?

A

While ratings are subjective and will change, the latest KARUNA THERAPEUTICS INC COM (KRTX) rating was a maintained with a price target of $330.00 to $330.00. The current price KARUNA THERAPEUTICS INC COM (KRTX) is trading at is $329.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.